Cargando…
Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective
PURPOSE: This article describes preclinical development of cell-based medicinal products for European markets and discusses European regulatory mechanisms open to developers to aid successful product development. Cell-based medicinal products are diverse, including cells that are autologous or allog...
Autores principales: | McBlane, James W., Phul, Parvinder, Sharpe, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156759/ https://www.ncbi.nlm.nih.gov/pubmed/29943208 http://dx.doi.org/10.1007/s11095-018-2437-y |
Ejemplares similares
-
Correction to: Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective
por: McBlane, James W., et al.
Publicado: (2018) -
Scientific and Legal Perspectives on Science Generated for Regulatory Activities
por: Henry, Carol J., et al.
Publicado: (2008) -
Future perspectives for advancing regulatory science of nanotechnology-enabled health products
por: Halamoda-Kenzaoui, Blanka, et al.
Publicado: (2022) -
Preclinical development of an automated injection device for intradermal delivery of a cell-based therapy
por: Leoni, Giulia, et al.
Publicado: (2017) -
Regulatory science of natural products
por: Goda, Yukihiro
Publicado: (2022)